chrisvoncsefalvay/vaers-outcomes huggingface dataset:
15mins post vacciantion pt had a syncopal event. Vitals: 113/80, 105, 18 Pt recovered quickly.  Pt stable and released from the vaccination site.
The day of the shot I had some pain on my right side body, right jaw... on Wednesday I was just very tired and slept a lot. Thursday morning I woke with pain in my hips and Pelvis, and around 9am pelvic pain started that felt as sever as the pain I felt giving birth (20 months ago). Thurs/Friday and today (Saturday) it?s been so painful I?ve had a hard time walking, laughing, coughing and caring for my toddler has been immensely challenging. My period began Friday afternoon, a heavier flow than usual. To be clear I have VERY mild periods and am a very healthy young woman. This is unlike anything I?ve ever experienced and the only thing that is different was receiving the vaccine and upon further research it seems MANY women of menstruating age have been experiencing abnormal periods. Today I am still in so much pain it?s debilitating however it is less sever than yesterday (Friday) and the fatigue also continues even after sleeping 10 hours last night.
Received Pneumovax on 11/3/04. Complaints of pain starting that evening, left elbow edema with transient arm edema. Cellulitis left arm; Rocephin and Keflex given.
Information has been received from a healthcare worker (immunization official) referring to a 4 year old patient. The patient's medical history, concurrent condition and concomitant therapy were not reported. On 12-AUG-2015, the patient was vaccinated with a dose of (Merck) VARIVAX, lot # K026387 (expiration date, dose and route not reported), which was improperly stored. No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
ITCHINESS AND SORE ARMPIT WITH LYMPHADENOPATHY DEVELOPED ON SIDE OF INJECTION. Narrative:
This spontaneous report was received from a certified medical assistant concerning unspecified number of patients of unknown age and gender. On an unknown date (also reported as since 11-MAY-2016) the patient was vaccinated with improperly stored dose of VAQTA. No adverse effect reported. The temperature excursion details included exposure to temperature of 47 Fahrenheit for 8 hours. No previous temperature excursions reported. No additional doses have been administered. This is one of several reports received from the same source. Additional information has been requested.
Sudden onset of shortness in breath No other symptoms preceding or following the impact Self medicated (using Seroflo 250 Salmeterol and Fluticasone inhaler) - got relief 30 minutes after taking this inhaler and went to bed. No symptoms the following day, as if nothing happened.
9/26: History of Present Illness   PT is a 67 yo female transferred from hospital on 9/26 for worsening AHRF due to COVID PNA. Patient on BiPAP upon arrival, 90% FiO2 (60% FiO2 when she left at hospital per transfer note). sx onset and diagnosis on 9/11, vaccinated with Moderna x2 in March. went to the ED at hospital, sent home on 2 L O2. Returned on 9/15 for worsening symptoms, admitted. s/p Dexamethasone, Remdesivir, and a single dose of Tocilizumab there. s/p Rocephin, discontinued due to low inflammatory markers per other hospital notes. Other hospital BLE doppler US negative for clots. No CT done per other hospital records. CXR with Patchy bilateral airspace opacities, consistent with known COVID-19 Pneumonia. Superimposed pulmonary edema is within consideration. Remarkable admission labs: CRP wnl. procal 0.11.Ferritin, LDH, D-dimer elevated. Mild LFT elevation. Leukocytosis. LA 3.3 Cr 1.02. Potassium 5.2. Patient had PICC line placed 9/15 due to hard stick.  9/27: Due to persistent hypoxia despite BiPAP, patient was intubated on 9/27. She became hypotensive, believed to be distributive shock. Infectious work-up as noted below, initiated broad spectrum coverage for hospital acquired pneumonia and possible PJP given her underlying immunosuppression. Right sided radial arterial line placed, which was replaced with a right sided femoral arterial line after this line failed. The patient was paralyzed, received additonal INO treatment, received an esophageal balloon, and was proned on 9/27.
Stabbing in the heart and under arm pit; Stabbing in the heart and under arm pit; Heart rate of 140; Fever; Chills; Tiredness; Muscle pain; Runny nose; Ear infection; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 36 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 29Mar2021 12:15 (Lot number: Er8732) at the age of 36 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: En6205, Location of injection: Arm Left, Vaccine Administration Time: 01:00 PM), administration date: 08Mar2021, when the patient was 36 years old, for COVID-19 immunization. The following information was reported: ANGINA PECTORIS (medically significant), AXILLARY PAIN (non-serious) all with onset 29Mar2021 23:00, outcome "recovered with sequelae" (2021) and all described as "Stabbing in the heart and under arm pit"; HEART RATE INCREASED (non-serious) with onset 29Mar2021 23:00, outcome "recovered with sequelae" (2021), described as "Heart rate of 140"; PYREXIA (non-serious) with onset 29Mar2021 23:00, outcome "recovered with sequelae" (2021), described as "Fever"; CHILLS (non-serious) with onset 29Mar2021 23:00, outcome "recovered with sequelae" (2021), described as "Chills"; FATIGUE (non-serious) with onset 29Mar2021 23:00, outcome "recovered with sequelae" (2021), described as "Tiredness"; MYALGIA (non-serious) with onset 29Mar2021 23:00, outcome "recovered with sequelae" (2021), described as "Muscle pain"; RHINORRHOEA (non-serious) with onset 29Mar2021 23:00, outcome "recovered with sequelae" (2021), described as "Runny nose"; EAR INFECTION (non-serious) with onset 29Mar2021 23:00, outcome "recovered with sequelae" (2021), described as "Ear infection". The patient underwent the following laboratory tests and procedures: heart rate: (29Mar2021) 140. Therapeutic measures were not taken as a result of angina pectoris, axillary pain, heart rate increased, pyrexia, chills, fatigue, myalgia, rhinorrhoea, ear infection.  Clinical course: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No other medications the patient received within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
No additional AE reported; administered to the patient after the excursion occured; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided.   On 26-MAY-2022, the patient was vaccinated with improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) 0.5 milliliter, lot #U039262, expiration date: 09-JUN-2023 (strength and route of administration were not provided) for prophylaxis (Product storage error).   On an unknown date, before the administration, the vaccine underwent temperature excursion at 6.0 Fahrenheit degrees (F) for 30 minutes. Previous temperature excursions were reported. No adverse events were reported (No adverse event).  This is one of several reports from the same reporter.
received their first dose 109 days ago; This spontaneous case was reported by a health care professional and describes the occurrence of INTENTIONAL PRODUCT USE ISSUE (received their first dose 109 days ago) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INTENTIONAL PRODUCT USE ISSUE (received their first dose 109 days ago). At the time of the report, INTENTIONAL PRODUCT USE ISSUE (received their first dose 109 days ago) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication information was not provided.  Treatment information was not provided.
GBS/ Guillium Barre Syndrome, paralizied from neck down after recovery chronic numbness, tingling and fatigue. Also nerve pain in arms and legs. Providers didn't do anything, prescribed flexirill, 800 mg ibrphrion and not much help. Didn't get any mental help till 2017.
Whole arm swollen for 5 days. Rash in arm. Fever for 2 days.
24 hours after administration mother noticed two raised bumps on child's face and four on trunk resembling pimples. Afebrile.
The patient is a 4 year, 1 month old male who presents with a complaint of vaccine reaction?. Patient received the IPV and Varicella vaccine into his RVL. Mom noted redness and swelling later that evening and called office yesterday to discuss. At that point there was a baseball sized induration and redness on his R outer thigh. Mom outlined margins, dosed with BENADRYL and monitored overnight. He woke this morning with spreading redness and the area is hot to touch. Mom also noted another area of redness on his inner R thigh and several papules on his L arm, scalp, and trunk. The lesions in the thigh itch rather than hurt. A similar reaction was noted after the 12 month VARIVAX (IPV not done that day). There have not been any similar reactions with any other vaccines including either of the two doses of MMR vaccine given in the contralateral thigh.
Patient felt slightly depressed Physically; Patient felt a little punk the next day; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Patient felt a little punk the next day) and GENERAL PHYSICAL CONDITION ABNORMAL (Patient felt slightly depressed Physically) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20S, 011A21A, 017F2A and 067F21A) for COVID-19 prophylaxis.     Concurrent medical conditions included Prostate cancer (The patient had Prostrate cancer since 2013. The patient was using Eligard for the cancer.) since 2013. Concomitant products included LEUPRORELIN ACETATE (ELIGARD) for Prostate cancer.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Mar-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced MALAISE (Patient felt a little punk the next day). On an unknown date, the patient experienced GENERAL PHYSICAL CONDITION ABNORMAL (Patient felt slightly depressed Physically). At the time of the report, MALAISE (Patient felt a little punk the next day) and GENERAL PHYSICAL CONDITION ABNORMAL (Patient felt slightly depressed Physically) outcome was unknown.            It was unknown if patient receives any other vaccines in the 4 weeks prior to COVID-19 vaccine.  Expiry date was not reported for any of the four doses.  Patient had felt a little punk next day after the first primary series dose and patient felt slightly depressed Physically after the first primary series dose. Patient did not experience any adverse event after the 2nd, 3rd and 4th dose.   Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2023-736300 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-736300:Master case (Same patient with differnet dose- Bivalent)
Information has been received on 02/28/02 from a licensed practical nurse concerning a female  who was vaccinated with with a dose of Varivax (site unknown). Subsequently, the patient had serology testing performed, and a varicella zoster IgG was negative on two separate occasions. It was noted that the reporter did not know when the serology testing was performed in relationship to when the vaccine was administered. There were no other details available. The patient sought unspecified medical attention. Additional information has been requested.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 67-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 02Apr2022 as dose 4 (booster), single (Lot number: FJ4991) at the age of 67 years for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 28Jan2021 as dose 1, single (Lot number: 032L20A), on 25Feb2021 as dose 2, single (Lot number: 001A21A) and on 08Oct2021 as dose 3 (booster), single (Lot number: 058E21A) for covid-19 immunisation. The patient's relevant medical history included: "GERD" (unspecified if ongoing); "arthritis" (unspecified if ongoing); "peripheral neuropathy" (unspecified if ongoing); "osteoporosis" (unspecified if ongoing); "situational anxiety" (unspecified if ongoing); "reactive airway disease" (unspecified if ongoing); "Known allergy:Sulfanomides" (unspecified if ongoing). Concomitant medication(s) included: PANTOPRAZOLE; FAMOTIDINE; CELECOXIB; AZELASTINE; GABAPENTIN; DULOXETINE; MONTELUKAST; ADVAIR; XANAX; PREMARIN; ESTRADIOL; PROLIA. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant) all with onset 2022, outcome "not recovered" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, suspected covid-19.  Additional information: Report about covid treatment was yes. If vaccine received reported as Yes. Other medication in 2weeks reported as Yes. Anti viral details product: COVID 19 Treatment, Brand: Paxlovid, treatment start date: 06May2022, treatment stop date: 11May2022, indication: Treatment of COVID-19.
Extreme vertigo/dizziness causing sudden fall. Ringing/tinnitus in ears. Pressure in head with a fogginess feeling. Unable to function, work or drive, for 4 days. All symptoms still present after 3 and a half weeks but have subsided to the point  I can function.
This report describes the occurrence of mercury poisoning in a male child of unspecified age who was vaccinated with hepatitis B vaccine for prophylaxis. This report was received as part of litigation proceedings and has not been verified by a physician or other health care professional. The subject's medical  history, concurrent conditions, and concurrent medications were not reported. The subject received injections of hepatitis B vaccine on 5/14/93, 6/18/93, and 5/10/94. He also received diphtheria and tetanus toxoids and pertussis vaccine, Haemophilus influenzae type B conjugate vaccine, oral poliomyelitis virus vaccine, MMR, and varicella virus vaccine. He received unspecified tuberculin tests on 5/14/93 and 6/23/98. The subject's attorney alleged that, as a result of mercury in thimerosal-adulterated infant injections that the subject received as an infant, he now suffers, and in the future will continue to suffer, from the toxic neurological effects of mercury poisoning. The attorney also alleged that the subject will be hindered and prevented from pursuing a normal course of employment.
Within 2 hours, post vax, pt developed swelling of face and extremities plus erythema. He also had sharply demarcated border of erythema where short/shorts/socks began. He had increased erythema with sun exposure. No new foods or changes in environment. He is recovering.
COVID 19 Treatment; COVID 19 Treatment; Interchange of vaccine products; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 27-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 11Mar2021 as dose 1, single (Lot number: EL8982), in left arm, on 01Apr2021 as dose 2, single (Lot number: EL898), in left arm and on 07Oct2021 as dose 3 (booster), single (Lot number: FF2590) at the age of 26 years, in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 04Jun2022 as dose 4 (booster), single (Batch/Lot number: unknown), in left arm and on 17Sep2022 as dose 5 (booster), single (Lot number: A57145B), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "eczema" (unspecified if ongoing); "ADHD" (unspecified if ongoing); "Peanut allergy" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 29May2023, outcome "not recovered" and all described as "COVID 19 Treatment"; INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 29May2023, outcome "not recovered", described as "Interchange of vaccine products ". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (29May2023) Positive, notes: I tested daily with Floflex rapid antigen tests throughout my illness; (05Jun2023) Negative. Therapeutic measures were taken as a result of events, the patient received paxlovid from 22May2023 to 03Jun2023.
Headache; Nausea; Chills; His head gets very lightheaded like he is going to faint/feel like I will pass out; Weakness; Brain fog; Fatigue; Increase in BP; This is a spontaneous report from a contactable consumer (patient)  A 38-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number/expiration date unknown) on 24Jul2021 at 10:30 at single dose via an unspecified route of administration  for COVID-19 immunization. Relevant medical history included diabetes Type 2, Seasonal allergy, he was sick on Dec2019 (with very similar s/s he experienced after the 1st vaccine dose) and suspected COVID-19 on Dec20219 (pharmacist told him he 'probably had Covid-19 in 12/2019 and that is why his symptoms are worse with the 1st dose). Concomitant medications were not reported. On 25Jul2021 nausea started and  since 26Jul2021 headache occurred. On an unspecified date he experienced  weakness and patient also reported that when he went into a crowded room he had to leave because he felt like I will pass out. Since an unspecified date he had brain fog, it was like his equilibrium was off in which he was dizzy (as reported), he had chills and is just really fatigued like he didn't want to get up. Patient also reported an increase in BP appeared since an unspecified date. The symptoms happened in morning and evening not all day. Patient informed that when he lied down, felt better. Patient also commented it's not like it's steady, the side effects usually occur in the morning when he first is waking up and at night. All the side effects are about the same, consistent. This freaks him out because his head gets very lightheaded like he is going to faint, and his Blood pressure rises, which then makes him anxious and stressing out.  He was due for his second dose on 13Aug2021. At the time of the reporting the patient had not recovered from nausea and chills, while outcome of other reported events was unknown.
chills after the 2nd dose of vaccine; fever of 101after the 2nd  dose of vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills after the 2nd dose of vaccine) and PYREXIA (fever of 101after the 2nd  dose of vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (chills after the 2nd dose of vaccine) and PYREXIA (fever of 101after the 2nd  dose of vaccine). At the time of the report, CHILLS (chills after the 2nd dose of vaccine) and PYREXIA (fever of 101after the 2nd  dose of vaccine) outcome was unknown.            Reporter did not allow further contact
Right shoulder erythematous, TTP, warm down to elbow, a few crusted insect bites on right back and right arm, tiny pustule at site of vaccine administration, no fluctuance.
Heartache started about a week after getting 2nd shot of Pfizer. Never had heart issues before in my life. I've noticed sharp, pulsing pain in the left side of my chest while in store. There pain pulses lasted for about a minute, then subsided. Since it subsided, I though it might have been muscle pain. However, I had the same pain happening 2 days later. Now it has been 2 weeks since my 2nd shot of Pfizer and I continue to get pulsing pain in heart area almost daily. It usually last anywhere from 1-3 minutes and then subsides. The pain is sharp, but tolerable, hence I did not go to a doctor with this issue yet. Again, I have never ever had this kind of pain in my life ago, nor I ever had any heart-related medical condition. I really hope it is temporary and will pass. For now I will continue to monitor and observe the symptoms.
With my first Moderna shot on 3/8/21 I did not have any adverse effects (the lot# for that dose was:  031M20A).  With my second dose, on 4/5/21, I had large, hot red splotches on my neck, chest and arm, not immediately, but after 24 hours (the lot# for that dose was:  048A21A).  I thought it may be a side effect and it went away within 5 days.  The 3rd dose I just received on 11/29/21, I had more hot red blotches on my neck and chest after 24 hours of receiving the vaccine.  When I showed a doctor friend of mine she said it looked like an allergic reaction and not a side effect.  I took Benadryl and it calmed the inflammation down.  It was definitely an allergic reaction.
Patient was given shot and asked to wait in pharmacy area at least 15 minutes.  Within about 5-10 minutes his girlfriend comes to the pharmacy window and tells me he's feeling bad.  By the time I get to his chair he is very lethargic and slumped over.  I sit him up in the chair and his head rolls back and his eyes have rolled back in his head.   I place him on the floor and instructed my staff to call 911.   The patient presented with sweats and was unresponsive for about 10-20 seconds.   When he came to he asked how he got on the floor.   The patient never had any trouble breathing  heart rate was steady the entire time.   When EMS arrived they checked him out and was fine.  He refused transport to the hospital.  He walked out of the store after about 30 minutes from the point of his passing out.
Bloody urine, fatigue, heaviness in legs nephrotic range proteinuria, hypoalbuminemia, nephrotic syndrome, Glomerulonephritis ISA nephropathy, Acute crescentric glomerulonephritis Acute Renal Failure PO and IV steroids Imuran, Lisinopril Cushing syndrome